The demand for the widely used cancer drug paclitaxel is increasing, but it’s difficult and expensive to produce because it ...

Global pharmaceutical giant Eli Lilly & Co. is seeking tax incentives for a potential 236-acre biomanufacturing plant in ...

Swiss pharma giant Roche is investing $280 million to build a new biopharma manufacturing facility in Shanghai, as it doubles ...

New research shows the technology’s potential to help find treatments for diseases that have baffled scientists.

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

Pfizer and RemeGen's HER2 antibody-drug conjugate delivered positive phase 3 results in a bladder cancer trial in China. | ...

Greentech and Roche are planning domestic manufacturing facilities, adding to the list of projects sparked by Trump's push ...

Novo Nordisk said this morning that it will work with the biotech Septerna to develop oral GLP-1 obesity drugs, as it races to catch up to Eli Lilly’s efforts to bring a more convenient weight ...

UK-based pharma major AstraZeneca (LSE: AZN) has started construction on a new manufacturing site for small molecule drugs in ...

Commerce officials approved an incentives package worth up to $13.1 million for the company, which plans to build a $700 ...

Xoted Biotechnology Labs opens in Duncan’s Spark Center, bringing biotech innovation, R&D, and sustainable manufacturing to ...